Weight Loss Drugs (BK2152) Stock Forum and Discussion

Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

1787.872
-15.305-0.85%

Close Jul 26 16:00 ET

1807.649High1783.690Low

Constituent Stocks: 7Top Rising: PFE+3.39%

Bruce Patton

Yesterday 08:58

Serve Robotics soars after Nvidia bet: Will you buy in?

HumbleHuman

Yesterday 03:14

$SGMO

chexk out the DD on this. Being funded by $Pfizer(PFE.US)$

HumbleHuman

Yesterday 03:12

$Sangamo Therapeutics(SGMO.US)$ its being funded by $Pfizer(PFE.US)$ that says it all… Holding - adding weekly here

MonkeyGee

Yesterday 00:45

PFE is moving like there is another pandemic coming!

$Pfizer(PFE.US)$

Pfizer(PFE) 30.735 +3.28%

iamiam

Jul 26 10:58

$Viking Therapeutics(VKTX.US)$
Hold 70 you bad ass 😍 $Viking Therapeutics(VKTX.US)$
$Viking Therapeutics(VKTX.US)$

Unsupported module. Please view on mobile devices.

joe black8

Jul 26 10:14

Lly instead of losing 100b in cap

$Viking Therapeutics(VKTX.US)$ could have bought this for 20b, what losers

TrendTrader

Jul 26 09:59

70 🎯 hit!

$Viking Therapeutics(VKTX.US)$

MonkeyGee

Jul 26 09:10

Allegedly some cancer drug got approved

$Pfizer(PFE.US)$

Pfizer(PFE) 30.393 +2.13%

Movers and Shakers

Jul 26 07:19

Columns Today's Morning Movers and Top Ratings: AAPL, MMM, NVDA, COIN and More

Morning Movers
Gapping up
$Coinbase(COIN.US)$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA(NVDA.US)$ , $Broadcom(AVGO.US)$ , $Qualcomm(QCOM.US)$ , and $Micron Technology(MU.US)$ all posting gains exceeding 2%. This movement came as the sector attempted to r...

Big tech earnings disappoint, US stocks dips: Who's the next hope?

BullnBearTrading

Jul 26 04:58

Viking Therapeutics Shares Surge Nearly 40% as Weight Loss Drug Advances, Eli Lilly Loses $120 Billion in Market Value

Shares of Viking Therapeutics soared nearly 40% intraday following discussions with the FDA that accelerated the development of their weight loss candidate VK2735 to phase 3 trials, potentially advancing its market debut by a year. This drug, administered monthly, is anticipated to be more convenient than Eli Lilly and Novo Nordisk's treatments. The oral version of VK2735 will be...

No comment yet